Resources | NITAG RESOURCE CENTER

2013 ∙ ACIP

Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine Among Children Aged 6–18 Years with Immunocompromising Conditions

2013 ∙ Conseil Supérieur de la Santé (CSS)

Vaccination against Seasonal Flu 2013-2014

2012 ∙ Cadeddu, C. De Waure, C. Gualano, M. R. Di Nardo, F. Ricciardi, W.

23-valent pneumococcal polysaccharide vaccine (PPV23) for the prevention of invasive pneumococcal diseases (IPDs) in the elderly: Is it really effective?

2012 ∙ Chan, Z. C. Chan, T. S. Ng, K. K. Wong, M. L.

A systematic review of literature about women's knowledge and attitudes toward human papillomavirus (HPV) vaccination

2012 ∙ Agarwal, N. Ollington, K. Kaneshiro, M. Frenck, R. Melmed, G. Y.

Are immunosuppressive medications associated with decreased responses to routine immunizations? A systematic review

2012 ∙ El-Makhzangy, A. M. Ismail, N. M. Galal, S. B. Sobhy, T. S. Hegazy, A. A.

Can vaccination against pneumococci prevent otitis media with effusion?

2012 ∙ Farkouh, R. A. Klok, R. M. Postma, M. J. Roberts, C. S. Strutton, D. R.

Cost-effectiveness models of pneumococcal conjugate vaccines: variability and impact of modeling assumptions

2012 ∙ Malagón, T. Drolet, M. Boily, M. C. Franco, E. L. Jit, M. Brisson, J. Brisson, M.

Cross-protective efficacy of two human papillomavirus vaccines: A systematic review and meta-analysis

2012 ∙ Kuo, A. M. Brown, J. N. Clinard, V.

Effect of influenza vaccination on international normalized ratio during chronic warfarin therapy